First trimester screening

Gynecologic and Obstetric Investigation

Volumn 60, Issue 1, 2005, Pages 58-62

  Ellestad, Sarah C ^a,c   Wells, Steven R ^a,b   Kuller, Jeffrey A ^a,b  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b Duke Perinatal Consultants   (United States)

^c DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Advanced maternal age; Aneuploidy; Maternal serum screening; Nuchal translucency

Indexed keywords

CHORIONIC GONADOTROPIN;

ANEUPLOIDY; ARTICLE; DIAGNOSTIC ACCURACY; DIAGNOSTIC APPROACH ROUTE; FETUS ECHOGRAPHY; FIRST TRIMESTER PREGNANCY; GENETIC RISK; GENETIC SCREENING; HUMAN; MATERNAL AGE; PRENATAL DIAGNOSIS; PRENATAL SCREENING; PRIORITY JOURNAL; RISK ASSESSMENT; SCREENING TEST; SECOND TRIMESTER PREGNANCY; TRISOMY 21;

ANEUPLOIDY; FEMALE; FETAL DISEASES; GENETIC DISEASES, INBORN; HUMANS; MASS SCREENING; PREGNANCY; PREGNANCY TRIMESTER, FIRST; PRENATAL DIAGNOSIS;

EID: 23244445218     PISSN: 03787346     EISSN: None     Source Type: Journal    
DOI: 10.1159/000083485     Document Type: Article

References (18)

1. Gabbe SG, Niebyl JR, Simpson JL: Obstetrics: Normal and problem pregnancies, ed 4. New York, Churchill Livingstone, 2002.
2. Mathews T, Hamilton B: Mean age of mother, 1970-2000. Natl Vital Stat Rep 2002;51:1-14.
3. Martin J, Hamilton B, Ventura S, Menacker F, Park M, Sutton P: Births: Final data for 2001. Natl Vital Stat Rep 2002;51:1-103.
4. Cuckle H: Time for total shift to first-trimester screening for Down's syndrome. Lancet 2001;358:1658-1659.
5. Wald NJ, Kennard A, Hackshaw AK, McGuire A: Antenatal screening for Down's syndrome. J Med Screen 1997;4:181-246.
6. Snijders RJ, Noble P, Sebire N, Souka A, Nicolaides KH: UK multicentre project on assessment of risk of trisomy 21 by maternal age and fetal nuchal-translucency thickness at 10-14 weeks of gestation. Fetal Medicine Foundation First Trimester Screening Group (comment). Lancet 1998;352:343-346.
7. Malone FD, Berkowitz RL, Canick JAP, D'Alton ME: First-trimester screening for aneuploidy: Research or standard of care? (Editorial). Am J Obstet Gynecol 2000;182:490-496.
8. Malone FD, D'Alton ME, Society for Maternal-Fetal M: First-trimester sonographic screening for Down syndrome. Obstet Gynecol 2003;102(Pt 1):1066-1079.
9. Moscoso G: Fetal nuchal translucency: A need to understand the physiological basis. Ultrasound Obstet Gynecol 1995;5:6-8.
10. Crossley JA, Aitken DA, Cameron AD, McBride E, Connor JM: Combined ultrasound and biochemical screening for Down's syndrome in the first trimester: A Scottish multicentre study. BJOG 2002;109:667-676.
11. D'Alton ME, Malone FD, Lambert-Messerlian G, et al: Maintaining quality assurance for nuchal translucency sonography in a prospective multicenter study: Results from the FASTER trial. Am J Obstet Gynecol 2003;189:S79.
12. Benn PA: Advances in prenatal screening for Down syndrome. II. First trimester testing, integrated testing, and future directions. Clin Chim Acta 2002;324:1-11.
13. Schuchter K, Hafner E, Stangl G, Metzenbauer M, Hofinger D, Philipp K: The first trimester 'combined test' for the detection of Down syndrome pregnancies in 4,939 unselected pregnancies. Pren Diagn 2002;22:211-215.
14. Wald NJ, Watt HC, Hackshaw AK: Integrated screening for Down's syndrome on the basis of tests performed during the first and second trimesters (see comment). N Engl J Med 1999;341:461-467.
15. Dugoff L, Hobbins J, Malone FD, et al: The association between first-trimester maternal serum PAPP-A and free beta-hCG concentrations and obstetric complications - A population-based screening study (the FASTER trial). Am J Obstet Gynecol 2003;189:S78.
16. Wald NJ, Rodeck C, Hackshaw AK, Walters J, Chitty L, Mackinson A: First and second trimester antenatal screening for Down's syndroms: The results of the Serum, Urine and Ultrasound Screening Study (SURUSS). J Med Screen 2003;10:56-104.
17. Malone FD, Wald NJ, Canick JAP, Ball RH, Nyberg DA, Comstock CH, Bukowski R, et al: First and second-trimester evaluation of risk (FASTER) trial: Principal results of the NICHD multicenter Down syndrome screening study. Am J Obstet Gynecol 2003;189:S56.
18. Wapner R, Thom E, Simpson JL, Pergament E, Silver R, Filkins K, Platt L, Mahoney M, et al: First-trimester screening for trisomies 21 and 18 (see comment). N Engl J Med 2003;349:1405-1413.